Hummingbird targets antibody discovery hurdle in fighting cancer
Sharanya Pillai
Singapore
ANTIBODIES is the buzzword in the race to cure cancer. Naturally produced by our immune systems, they can be used as drugs to bind to target proteins and invoke certain effects, such as destroying cancer cells.
But the industry bottleneck is that once researchers identify a good target protein, it is difficult to find the right antibodies to act against it.
TRENDING NOW
Ohmyhome Ltd sells real estate business for token US$1 due to poor business and continued losses
Buyer for England striker Harry Kane’s former mansion must pay £3.4 million after abandoning deal
As luxury retail goes big, can Singapore’s Orchard Road keep up?
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan